Eli Lilly and Company against Moderna, Inc. — live side-by-side technical comparison.
Prices as of 2026-09-23T20:03:35+00:00 UTC · updates daily
MRNA leads 5 of the 5 windows we measure — over 1 month LLY is -7.7% and MRNA +31.1%; over year to date LLY is +7.1% and MRNA +517.5%. The LLY/MRNA price ratio stands at 6.3203, below its 50-day average of 13.9402, and below the 200-day average of 20.3024. A ratio above its own average means LLY is gaining on MRNA; on this reading the recent edge belongs to MRNA.
| LLY | MRNA | |
|---|---|---|
| Price | $1150.99 | $182.11 |
| 1 day | -1.6% | -0.2%lead |
| 5 days | +1.2% | +25.1%lead |
| 1 month | -7.7% | +31.1%lead |
| 6 months | +26.4% | +255.1%lead |
| Year to date | +7.1% | +517.5%lead |
| 52-week position | 76% of range | 94% of range |
| 52-week range | $712.05–$1292.65 | $22.28–$192.31 |
| vs 50-day average | below $1176.62 | above $104.86 |
| vs 200-day average | above $1068.31 | above $62.57 |
| RSI (14) | 46 | 70 |
| Next earnings | 2026-10-29 | 2026-11-05 |
LLY trades at $1,150.99, below its 50-day average of $1,176.62, and above the 200-day at $1,068.31. It sits at 76% of its 52-week range ($712.05–$1,292.65); 14-day RSI is 46, in neutral territory; an average session moves it about 2.4%. For levels, the first level overhead is $1,176.62 (2.2% away) and the first support below is $1,150.00 (0.1% down). On the checklist the page runs for every asset, 4 of 6 checks read bullish — the lean is bullish.
MRNA trades at $182.11, above its 50-day average of $104.86, and above the 200-day at $62.57. It sits at 94% of its 52-week range ($22.28–$192.31); 14-day RSI is 70, in overbought territory; an average session moves it about 6.3%. For levels, the first level overhead is $182.56 (0.2% away) and the first support below is $175.00 (3.9% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
MRNA is the more volatile of the two — an average session moves it 6.3% against 2.4% for LLY, so an identical position size carries roughly 2.6× the daily risk.
The comparison turns on those levels: LLY clearing $1,176.62 or losing $1,150.00; MRNA clearing $182.56 or losing $175.00. Until one of them gives way, the relative reading above stands.